RhythmScience, Inc. — Form D
RhythmScience, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-03. The offering totals $7.5M, of which $6.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-04-03
- Form: D
- Accession: 0001213900-23-026146
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $7.5M
- Amount sold: $6.0M
- Remaining: $1.5M
- Minimum investment: $20K
- Investors: 3
- Date of first sale: 2023-03-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-477746
Issuer
- Name: RhythmScience, Inc.
- CIK: 0001970399
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 81 LANGTON ST., SAN FRANCISCO, CA, 94103
- Phone: 844-420-0024
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Eytan Elbaz | Director | Los Angeles, CA |
| Maureen Klewicki | Director | Los Angeles, CA |
| Shawn Kumar | Director | San Francisco, CA |
| Shawn Kumar | Executive Officer | San Francisco, CA |
More